📚 Whole-Keyword Library Bundle · 25% Bulk Discount

NIH ClinicalTrials.gov Interventional Pipeline

Newly updated interventional and observational clinical trial registrations from the NIH ClinicalTrials.gov v2 registry.

MATCHING PAYWALLS
1,005 (40 in Pack)
WHOLE-PACK BULK PRICE
$0.150 USD in XNO
CONTRIBUTING SUBDOMAINS
clinical-trials.withsilex.com, dispatch.withsilex.com
LATEST VERIFIED UTC
2026-11-17 14:15 UTC
🆓 Free Public Citation & Sample Record #1 (clinical-trials.withsilex.com)

Recently updated NIH study NCT07672483 (RECRUITING): IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors

{
  "nct_id": "NCT07672483",
  "title": "IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors",
  "status": "RECRUITING",
  "phase": "PHASE1",
  "conditions": "Relapsed Solid Tumor Malignancies; Refractory Solid Tumor Malignancies",
  "verify_url": "https://clinicaltrials.gov/study/NCT07672483"
}
🔓 UNLOCKED WHOLE KEYWORD LIBRARY (40 DATASETS)
{"id":"pulse_clinical-trials_20261112-1315","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261112-1315","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"ee17b6f54ace05aeffb344ef3305dc092d8789d2f1d7f03ff958469eae82276d","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-12T13:15:43.355Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT07672483 (RECRUITING): IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors","executive_summary":"Recently updated NIH study NCT07672483 (RECRUITING): IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07672483, NCT07800182, NCT06723171)","delta_changed_count":6,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT07672483","title":"IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors","status":"RECRUITING","phase":"PHASE1","conditions":"Relapsed Solid Tumor Malignancies; Refractory Solid Tumor Malignancies","verify_url":"https://clinicaltrials.gov/study/NCT07672483"},{"nct_id":"NCT07800182","title":"A Randomized Controlled Trial of Prepared vs. Unprepared Food","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Pregnant Patients at Risk of Gestational Diabetes","verify_url":"https://clinicaltrials.gov/study/NCT07800182"},{"nct_id":"NCT06723171","title":"Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis","status":"SUSPENDED","phase":"PHASE2","conditions":"Psoriasis; Plaque Type Psorisis; Plaque Psoriasis","verify_url":"https://clinicaltrials.gov/study/NCT06723171"},{"nct_id":"NCT07578363","title":"An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults","status":"RECRUITING","phase":"PHASE3","conditions":"Ocular Hyperemia","verify_url":"https://clinicaltrials.gov/study/NCT07578363"},{"nct_id":"NCT03712605","title":"Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE3","conditions":"Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8; Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8; Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8","verify_url":"https://clinicaltrials.gov/study/NCT03712605"},{"nct_id":"NCT07522931","title":"Systematic Anatomical Description of the Female Pelvic Retroperitoneum in Cadavers","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Pelvic Anatomy; Retroperitoneum; Cadaveric Study","verify_url":"https://clinicaltrials.gov/study/NCT07522931"}],"signal_sha256":"ee17b6f54ace05aeffb344ef3305dc092d8789d2f1d7f03ff958469eae82276d"}}
{"id":"pulse_clinical-trials_20261113-1445","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261113-1445","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"fc187f9a374a8ae610f254a9876f41df2a5b52c112bfedb4449557d52dffcb3b","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-13T14:45:43.210Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","executive_summary":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07936916, NCT07154511, NCT07935447)","delta_changed_count":6,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"},{"nct_id":"NCT03367741","title":"Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE2","conditions":"Advanced Endometrial Carcinoma; Metastatic Endometrial Carcinoma; Recurrent Endometrial Carcinoma","verify_url":"https://clinicaltrials.gov/study/NCT03367741"},{"nct_id":"NCT07213973","title":"Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa","status":"RECRUITING","phase":"PHASE2","conditions":"Hidradenitis Suppurativa (HS)","verify_url":"https://clinicaltrials.gov/study/NCT07213973"},{"nct_id":"NCT04439266","title":"Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE2","conditions":"Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm","verify_url":"https://clinicaltrials.gov/study/NCT04439266"}],"signal_sha256":"fc187f9a374a8ae610f254a9876f41df2a5b52c112bfedb4449557d52dffcb3b"}}
{"id":"pulse_clinical-trials_20261116-1315","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261116-1315","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"1ec3dfa55109b4e43619469b6f04672c19f435bd4c033740df05d695304ce873","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-16T13:15:50.095Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT07932509 (RECRUITING): Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in Burned Patients","executive_summary":"Recently updated NIH study NCT07932509 (RECRUITING): Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in Burned Patients","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07932509, NCT07938034, NCT07764107)","delta_changed_count":6,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT07932509","title":"Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in Burned Patients","status":"RECRUITING","phase":"NA","conditions":"Burns","verify_url":"https://clinicaltrials.gov/study/NCT07932509"},{"nct_id":"NCT07938034","title":"A Study of SYH2053 Injection in Participants With Renal Impairment Compared to Participants With Normal Renal Function","status":"RECRUITING","phase":"PHASE1","conditions":"Renal Impairment","verify_url":"https://clinicaltrials.gov/study/NCT07938034"},{"nct_id":"NCT07764107","title":"Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy Device","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Insomnia","verify_url":"https://clinicaltrials.gov/study/NCT07764107"},{"nct_id":"NCT07662304","title":"Effect of Continuous Supraglottic Oxygen Insufflation Via Video Laryngoscope Blade on Apneic Oxygenation During Tracheal Intubation Und","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Apneic Oxygenation","verify_url":"https://clinicaltrials.gov/study/NCT07662304"},{"nct_id":"NCT07938333","title":"Impact of Vitamin D on Gut Microbiome and Metabolome Among Pediatric Oncology Patients","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Acute Lymphoblastic Leukemia ALL","verify_url":"https://clinicaltrials.gov/study/NCT07938333"},{"nct_id":"NCT07730021","title":"A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Locally Advanced or Metastatic Solid Tumors","verify_url":"https://clinicaltrials.gov/study/NCT07730021"}],"signal_sha256":"1ec3dfa55109b4e43619469b6f04672c19f435bd4c033740df05d695304ce873"}}
{"id":"pulse_clinical-trials_20261117-1415","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261117-1415","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"d036695b2ec6fcdc828a9d4e780292926a344beb0147017b5014959d0be7f9fd","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-17T14:15:46.683Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT07941791 (NOT_YET_RECRUITING): Acute Effects of Table Tennis, Resistance Band Training, Brisk Walking, and Baduanjin on Working Memory in Older Adults With Mild Cogni","executive_summary":"Recently updated NIH study NCT07941791 (NOT_YET_RECRUITING): Acute Effects of Table Tennis, Resistance Band Training, Brisk Walking, and Baduanjin on Working Memory in Older Adults With Mild Cogni","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07941791, NCT07506655, NCT07890935)","delta_changed_count":6,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT07941791","title":"Acute Effects of Table Tennis, Resistance Band Training, Brisk Walking, and Baduanjin on Working Memory in Older Adults With Mild Cogni","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Mild Cognitive Impairment","verify_url":"https://clinicaltrials.gov/study/NCT07941791"},{"nct_id":"NCT07506655","title":"Comparison of Tracheal Intubation in Ramp vs Sniffing Position Using Customized vs Fixed Pillow","status":"COMPLETED","phase":"NA","conditions":"Elective Surgery; General Anesthesia","verify_url":"https://clinicaltrials.gov/study/NCT07506655"},{"nct_id":"NCT07890935","title":"Effects of Root Extract Ashwagandha (KSM-66) on Perception of Recovery and Muscle Strength in Adolescents Aged 11 to 19 Engaged in Gras","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Strength; Stress; Exercise Adaptation","verify_url":"https://clinicaltrials.gov/study/NCT07890935"},{"nct_id":"NCT07325474","title":"Plan and Protect: Safety Planning for Teens in Rural Emergency Departments","status":"RECRUITING","phase":"NA","conditions":"Suicide Ideation; Suicide Attempt","verify_url":"https://clinicaltrials.gov/study/NCT07325474"},{"nct_id":"NCT07834723","title":"NIV-NAVA in Infants With Severe Bronchiolitis, a Pilot Multicenter Randomized Controlled Trial","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Severe Bronchiolitis; Pediatric Respiratory Distress","verify_url":"https://clinicaltrials.gov/study/NCT07834723"},{"nct_id":"NCT07308860","title":"Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended","status":"ACTIVE_NOT_RECRUITING","phase":"OBSERVATIONAL","conditions":"Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT07308860"}],"signal_sha256":"d036695b2ec6fcdc828a9d4e780292926a344beb0147017b5014959d0be7f9fd"}}
{"id":"vault_clinical-trials_1","url":"https://clinical-trials.withsilex.com/v1/biomed/healthcare/feed-1","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"cffe93f4250e83fa14b10141a5b5111c1a4fe66835589fa7672e4b93fed4d363","data":{"protocol":"WithSilex-x402/1.2.7","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","vaultId":"vault_clinical-trials_1","title":"Phase-III Primary Endpoint & Biomarker Deltas — Drop #1","freshnessIso":"2026-11-11T17:00:02.107Z","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","executive_summary":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","record_count":6,"records":[{"nct_id":"NCT00794352","title":"Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Central Nervous System Disease; Multiple Sclerosis","verify_url":"https://clinicaltrials.gov/study/NCT00794352"},{"nct_id":"NCT04128748","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplast","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1/PHASE2","conditions":"Acute Myeloid Leukemia; Blasts More Than 10 Percent of Bone Marrow Nucleated Cells; High Risk Myelodysplastic Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT04128748"},{"nct_id":"NCT07624149","title":"TMS and Botulinum Toxin in Post-Stroke Upper Limb Spasticity","status":"COMPLETED","phase":"NA","conditions":"Post-stroke Spasticity of the Upper Limb","verify_url":"https://clinicaltrials.gov/study/NCT07624149"},{"nct_id":"NCT07929415","title":"Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery","status":"RECRUITING","phase":"NA","conditions":"Rectal Cancer","verify_url":"https://clinicaltrials.gov/study/NCT07929415"},{"nct_id":"NCT06217120","title":"Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","phase":"PHASE2","conditions":"Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT06217120"},{"nct_id":"NCT07796373","title":"Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inh","status":"NOT_YET_RECRUITING","phase":"PHASE2","conditions":"Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia","verify_url":"https://clinicaltrials.gov/study/NCT07796373"}],"signal_sha256":"cffe93f4250e83fa14b10141a5b5111c1a4fe66835589fa7672e4b93fed4d363"}}
{"id":"vault_clinical-trials_2","url":"https://clinical-trials.withsilex.com/v1/biomed/healthcare/feed-2","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"634fedad8a78613feea454c2113acb9722c3b13c8950771818d0a75ac123097d","data":{"protocol":"WithSilex-x402/1.2.7","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","vaultId":"vault_clinical-trials_2","title":"Phase-III Primary Endpoint & Biomarker Deltas — Drop #2","freshnessIso":"2026-11-11T17:00:02.107Z","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","executive_summary":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","record_count":6,"records":[{"nct_id":"NCT00794352","title":"Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Central Nervous System Disease; Multiple Sclerosis","verify_url":"https://clinicaltrials.gov/study/NCT00794352"},{"nct_id":"NCT04128748","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplast","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1/PHASE2","conditions":"Acute Myeloid Leukemia; Blasts More Than 10 Percent of Bone Marrow Nucleated Cells; High Risk Myelodysplastic Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT04128748"},{"nct_id":"NCT07624149","title":"TMS and Botulinum Toxin in Post-Stroke Upper Limb Spasticity","status":"COMPLETED","phase":"NA","conditions":"Post-stroke Spasticity of the Upper Limb","verify_url":"https://clinicaltrials.gov/study/NCT07624149"},{"nct_id":"NCT07929415","title":"Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery","status":"RECRUITING","phase":"NA","conditions":"Rectal Cancer","verify_url":"https://clinicaltrials.gov/study/NCT07929415"},{"nct_id":"NCT06217120","title":"Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","phase":"PHASE2","conditions":"Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT06217120"},{"nct_id":"NCT07796373","title":"Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inh","status":"NOT_YET_RECRUITING","phase":"PHASE2","conditions":"Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia","verify_url":"https://clinicaltrials.gov/study/NCT07796373"}],"signal_sha256":"634fedad8a78613feea454c2113acb9722c3b13c8950771818d0a75ac123097d"}}
{"id":"pulse_clinical-trials_20261111-1626","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261111-1626","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"9e5082cbc60546703452c65aba2a2d671cb6e27ba6167b41082dbb71ec383b7c","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-11T16:26:34.419Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","executive_summary":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","delta_changed_count":0,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT00794352","title":"Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Central Nervous System Disease; Multiple Sclerosis","verify_url":"https://clinicaltrials.gov/study/NCT00794352"},{"nct_id":"NCT04128748","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplast","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1/PHASE2","conditions":"Acute Myeloid Leukemia; Blasts More Than 10 Percent of Bone Marrow Nucleated Cells; High Risk Myelodysplastic Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT04128748"},{"nct_id":"NCT07624149","title":"TMS and Botulinum Toxin in Post-Stroke Upper Limb Spasticity","status":"COMPLETED","phase":"NA","conditions":"Post-stroke Spasticity of the Upper Limb","verify_url":"https://clinicaltrials.gov/study/NCT07624149"},{"nct_id":"NCT07929415","title":"Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery","status":"RECRUITING","phase":"NA","conditions":"Rectal Cancer","verify_url":"https://clinicaltrials.gov/study/NCT07929415"},{"nct_id":"NCT06217120","title":"Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","phase":"PHASE2","conditions":"Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT06217120"},{"nct_id":"NCT07796373","title":"Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inh","status":"NOT_YET_RECRUITING","phase":"PHASE2","conditions":"Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia","verify_url":"https://clinicaltrials.gov/study/NCT07796373"}],"signal_sha256":"9e5082cbc60546703452c65aba2a2d671cb6e27ba6167b41082dbb71ec383b7c"}}
{"id":"pulse_clinical-trials_20261111-1630","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261111-1630","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"bba6d033b7edfd3a2077ad9125074e02104e30fd90f2a61e3578300bb4c5725e","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-11T16:30:02.404Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","executive_summary":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","delta_changed_count":0,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT00794352","title":"Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Central Nervous System Disease; Multiple Sclerosis","verify_url":"https://clinicaltrials.gov/study/NCT00794352"},{"nct_id":"NCT04128748","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplast","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1/PHASE2","conditions":"Acute Myeloid Leukemia; Blasts More Than 10 Percent of Bone Marrow Nucleated Cells; High Risk Myelodysplastic Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT04128748"},{"nct_id":"NCT07624149","title":"TMS and Botulinum Toxin in Post-Stroke Upper Limb Spasticity","status":"COMPLETED","phase":"NA","conditions":"Post-stroke Spasticity of the Upper Limb","verify_url":"https://clinicaltrials.gov/study/NCT07624149"},{"nct_id":"NCT07929415","title":"Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery","status":"RECRUITING","phase":"NA","conditions":"Rectal Cancer","verify_url":"https://clinicaltrials.gov/study/NCT07929415"},{"nct_id":"NCT06217120","title":"Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","phase":"PHASE2","conditions":"Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT06217120"},{"nct_id":"NCT07796373","title":"Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inh","status":"NOT_YET_RECRUITING","phase":"PHASE2","conditions":"Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia","verify_url":"https://clinicaltrials.gov/study/NCT07796373"}],"signal_sha256":"bba6d033b7edfd3a2077ad9125074e02104e30fd90f2a61e3578300bb4c5725e"}}
{"id":"pulse_clinical-trials_20261111-1631","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261111-1631","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"52ff901d0c6b48414fa94cc3dc17371df760b34b2887ba710ad069b93da9f437","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-11T16:31:34.689Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","executive_summary":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","delta_changed_count":0,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT00794352","title":"Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Central Nervous System Disease; Multiple Sclerosis","verify_url":"https://clinicaltrials.gov/study/NCT00794352"},{"nct_id":"NCT04128748","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplast","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1/PHASE2","conditions":"Acute Myeloid Leukemia; Blasts More Than 10 Percent of Bone Marrow Nucleated Cells; High Risk Myelodysplastic Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT04128748"},{"nct_id":"NCT07624149","title":"TMS and Botulinum Toxin in Post-Stroke Upper Limb Spasticity","status":"COMPLETED","phase":"NA","conditions":"Post-stroke Spasticity of the Upper Limb","verify_url":"https://clinicaltrials.gov/study/NCT07624149"},{"nct_id":"NCT07929415","title":"Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery","status":"RECRUITING","phase":"NA","conditions":"Rectal Cancer","verify_url":"https://clinicaltrials.gov/study/NCT07929415"},{"nct_id":"NCT06217120","title":"Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","phase":"PHASE2","conditions":"Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT06217120"},{"nct_id":"NCT07796373","title":"Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inh","status":"NOT_YET_RECRUITING","phase":"PHASE2","conditions":"Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia","verify_url":"https://clinicaltrials.gov/study/NCT07796373"}],"signal_sha256":"52ff901d0c6b48414fa94cc3dc17371df760b34b2887ba710ad069b93da9f437"}}
{"id":"pulse_clinical-trials_20261111-1645","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261111-1645","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"91d19b06119d48fbae60daada8409e1e7deda8138161776cca4a282b0267381d","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-11T16:45:01.920Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","executive_summary":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","delta_changed_count":0,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT00794352","title":"Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Central Nervous System Disease; Multiple Sclerosis","verify_url":"https://clinicaltrials.gov/study/NCT00794352"},{"nct_id":"NCT04128748","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplast","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1/PHASE2","conditions":"Acute Myeloid Leukemia; Blasts More Than 10 Percent of Bone Marrow Nucleated Cells; High Risk Myelodysplastic Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT04128748"},{"nct_id":"NCT07624149","title":"TMS and Botulinum Toxin in Post-Stroke Upper Limb Spasticity","status":"COMPLETED","phase":"NA","conditions":"Post-stroke Spasticity of the Upper Limb","verify_url":"https://clinicaltrials.gov/study/NCT07624149"},{"nct_id":"NCT07929415","title":"Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery","status":"RECRUITING","phase":"NA","conditions":"Rectal Cancer","verify_url":"https://clinicaltrials.gov/study/NCT07929415"},{"nct_id":"NCT06217120","title":"Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","phase":"PHASE2","conditions":"Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT06217120"},{"nct_id":"NCT07796373","title":"Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inh","status":"NOT_YET_RECRUITING","phase":"PHASE2","conditions":"Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia","verify_url":"https://clinicaltrials.gov/study/NCT07796373"}],"signal_sha256":"91d19b06119d48fbae60daada8409e1e7deda8138161776cca4a282b0267381d"}}
{"id":"pulse_clinical-trials_20261111-1700","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261111-1700","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"c40370c45f826b3ada293c03f18a73adf1f242e2af73255fac007f08358ab3bf","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-11T17:00:01.857Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","executive_summary":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","delta_changed_count":0,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT00794352","title":"Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Central Nervous System Disease; Multiple Sclerosis","verify_url":"https://clinicaltrials.gov/study/NCT00794352"},{"nct_id":"NCT04128748","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplast","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1/PHASE2","conditions":"Acute Myeloid Leukemia; Blasts More Than 10 Percent of Bone Marrow Nucleated Cells; High Risk Myelodysplastic Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT04128748"},{"nct_id":"NCT07624149","title":"TMS and Botulinum Toxin in Post-Stroke Upper Limb Spasticity","status":"COMPLETED","phase":"NA","conditions":"Post-stroke Spasticity of the Upper Limb","verify_url":"https://clinicaltrials.gov/study/NCT07624149"},{"nct_id":"NCT07929415","title":"Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery","status":"RECRUITING","phase":"NA","conditions":"Rectal Cancer","verify_url":"https://clinicaltrials.gov/study/NCT07929415"},{"nct_id":"NCT06217120","title":"Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","phase":"PHASE2","conditions":"Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT06217120"},{"nct_id":"NCT07796373","title":"Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inh","status":"NOT_YET_RECRUITING","phase":"PHASE2","conditions":"Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia","verify_url":"https://clinicaltrials.gov/study/NCT07796373"}],"signal_sha256":"c40370c45f826b3ada293c03f18a73adf1f242e2af73255fac007f08358ab3bf"}}
{"id":"pulse_clinical-trials_20261111-1715","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261111-1715","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"dd419dee6706a570765cbc1ba35c806372a03d530be41b8a6cbb06a74c5ca05f","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-11T17:15:02.372Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","executive_summary":"Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","delta_changed_count":0,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT00794352","title":"Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Central Nervous System Disease; Multiple Sclerosis","verify_url":"https://clinicaltrials.gov/study/NCT00794352"},{"nct_id":"NCT04128748","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplast","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1/PHASE2","conditions":"Acute Myeloid Leukemia; Blasts More Than 10 Percent of Bone Marrow Nucleated Cells; High Risk Myelodysplastic Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT04128748"},{"nct_id":"NCT07624149","title":"TMS and Botulinum Toxin in Post-Stroke Upper Limb Spasticity","status":"COMPLETED","phase":"NA","conditions":"Post-stroke Spasticity of the Upper Limb","verify_url":"https://clinicaltrials.gov/study/NCT07624149"},{"nct_id":"NCT07929415","title":"Single Versus Double Stapling and Two Purse-String Techniques in Rectal Cancer Surgery","status":"RECRUITING","phase":"NA","conditions":"Rectal Cancer","verify_url":"https://clinicaltrials.gov/study/NCT07929415"},{"nct_id":"NCT06217120","title":"Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","phase":"PHASE2","conditions":"Heart Failure With Preserved Ejection Fraction; Microvascular Coronary Artery Disease","verify_url":"https://clinicaltrials.gov/study/NCT06217120"},{"nct_id":"NCT07796373","title":"Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inh","status":"NOT_YET_RECRUITING","phase":"PHASE2","conditions":"Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia","verify_url":"https://clinicaltrials.gov/study/NCT07796373"}],"signal_sha256":"dd419dee6706a570765cbc1ba35c806372a03d530be41b8a6cbb06a74c5ca05f"}}
{"id":"synth_biomed-fda-grants_20261113-1445","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-1445","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"c5ef5fbe4a54e9b49cfc28a7ada66b0d0aed30b601790bbf5405883e4687058e","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T14:45:43.210Z","slot_compact":"20261113-1445","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: +6 new primary record(s) since prior slot (NCT07936916, NCT071545 · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07936916, NCT07154511, NCT07935447)","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"76147-235","generic_name":"AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","brand_name":"StriVectin multi-action Super-C SPF 30","dosage_form":"CREAM","labeler":"StriVectin Operating Company, Inc.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"80425-0133","generic_name":"Pantoprazole Sodium","brand_name":"Pantoprazole Sodium DR","dosage_form":"TABLET, DELAYED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"},{"product_ndc":"80425-0396","generic_name":"VENLAFAXINE HYDROCHLORIDE","brand_name":"Venlafaxine Hydrochloride","dosage_form":"CAPSULE, EXTENDED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"c5ef5fbe4a54e9b49cfc28a7ada66b0d0aed30b601790bbf5405883e4687058e"}}
{"id":"synth_biomed-fda-grants_20261116-1315","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261116-1315","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"f46bc67a6cc27e5821fedac2cf28385c77827118a8d38582990f9d9e41bf0870","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-16T13:15:50.095Z","slot_compact":"20261116-1315","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07932509 (RECRUITING): Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in... | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: +6 new primary record(s) since prior slot (NCT07932509, NCT079380 · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07932509, NCT07938034, NCT07764107)","what_happened":"Recently updated NIH study NCT07932509 (RECRUITING): Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in Burned Patients","top_records":[{"nct_id":"NCT07932509","title":"Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in Burned Patients","status":"RECRUITING","phase":"NA","conditions":"Burns","verify_url":"https://clinicaltrials.gov/study/NCT07932509"},{"nct_id":"NCT07938034","title":"A Study of SYH2053 Injection in Participants With Renal Impairment Compared to Participants With Normal Renal Function","status":"RECRUITING","phase":"PHASE1","conditions":"Renal Impairment","verify_url":"https://clinicaltrials.gov/study/NCT07938034"},{"nct_id":"NCT07764107","title":"Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy Device","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Insomnia","verify_url":"https://clinicaltrials.gov/study/NCT07764107"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"7K01AA029712-06","principal_investigator":"GRODIN, ERICA N","institution":"ARIZONA STATE UNIVERSITY-TEMPE CAMPUS","award_usd":100038,"title":"Characterizing the Microbiome-Gut-Brain Axis in Individuals with Alcohol Use Disorder","reporter_url":"https://reporter.nih.gov/project-details/11647352"},{"grant_id":"5P20GM139733-04","principal_investigator":"ZHANG, E (ALICE) ","institution":"UNIVERSITY OF KANSAS MEDICAL CENTER","award_usd":232500,"title":"Advancing OASIS Parent Training Toward Real-World Effectiveness in Community ABA Agencies","reporter_url":"https://reporter.nih.gov/project-details/11694438"}]}],"signal_sha256":"f46bc67a6cc27e5821fedac2cf28385c77827118a8d38582990f9d9e41bf0870"}}
{"id":"synth_biomed-fda-grants_20261112-1315","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261112-1315","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"ae8b209b3fb023f975e309093401dad0c60a226c29d8e430a0605f106053d10c","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-12T13:15:43.355Z","slot_compact":"20261112-1315","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07672483 (RECRUITING): IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid... | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: +6 new primary record(s) since prior slot (NCT07672483, NCT078001 · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07672483, NCT07800182, NCT06723171)","what_happened":"Recently updated NIH study NCT07672483 (RECRUITING): IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors","top_records":[{"nct_id":"NCT07672483","title":"IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors","status":"RECRUITING","phase":"PHASE1","conditions":"Relapsed Solid Tumor Malignancies; Refractory Solid Tumor Malignancies","verify_url":"https://clinicaltrials.gov/study/NCT07672483"},{"nct_id":"NCT07800182","title":"A Randomized Controlled Trial of Prepared vs. Unprepared Food","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Pregnant Patients at Risk of Gestational Diabetes","verify_url":"https://clinicaltrials.gov/study/NCT07800182"},{"nct_id":"NCT06723171","title":"Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis","status":"SUSPENDED","phase":"PHASE2","conditions":"Psoriasis; Plaque Type Psorisis; Plaque Psoriasis","verify_url":"https://clinicaltrials.gov/study/NCT06723171"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0002-9307","generic_name":"Insulin human","brand_name":"Insulin human","dosage_form":"CRYSTAL","labeler":"Eli Lilly and Company","marketing_category":"BULK INGREDIENT"},{"product_ndc":"87910-005","generic_name":"ALCOHOL 75%","brand_name":"Hydrating Hand Sanitizer ALOE BREEZE","dosage_form":"LIQUID","labeler":"Guangzhou Ailizhuangsi Cosmetics Co., Ltd.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"98132-010","generic_name":"TITANIUM DIOXIDE and ZINC OXIDE","brand_name":"bareMinerals Original Foundation Broad Spectrum SPF 15 Light 08","dosage_form":"POWDER","labeler":"Orveon Global US LLC","marketing_category":"OTC MONOGRAPH DRUG"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"ae8b209b3fb023f975e309093401dad0c60a226c29d8e430a0605f106053d10c"}}
{"id":"synth_biomed-fda-grants_20261117-1415","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261117-1415","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"a5fae81bc335e0a115f9ee780dc3aca5a78016e9cfb7e5e0a424756c4380f057","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-17T14:15:46.683Z","slot_compact":"20261117-1415","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07941791 (NOT_YET_RECRUITING): Acute Effects of Table Tennis, Resistance Band Training, Brisk Walking, and... | [cold-chain] Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157...","delta_since_last_slot":"clinical-trials: +6 new primary record(s) since prior slot (NCT07941791, NCT075066 · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07941791, NCT07506655, NCT07890935)","what_happened":"Recently updated NIH study NCT07941791 (NOT_YET_RECRUITING): Acute Effects of Table Tennis, Resistance Band Training, Brisk Walking, and Baduanjin on Working Memory in Older Adults With Mild Cogni","top_records":[{"nct_id":"NCT07941791","title":"Acute Effects of Table Tennis, Resistance Band Training, Brisk Walking, and Baduanjin on Working Memory in Older Adults With Mild Cogni","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Mild Cognitive Impairment","verify_url":"https://clinicaltrials.gov/study/NCT07941791"},{"nct_id":"NCT07506655","title":"Comparison of Tracheal Intubation in Ramp vs Sniffing Position Using Customized vs Fixed Pillow","status":"COMPLETED","phase":"NA","conditions":"Elective Surgery; General Anesthesia","verify_url":"https://clinicaltrials.gov/study/NCT07506655"},{"nct_id":"NCT07890935","title":"Effects of Root Extract Ashwagandha (KSM-66) on Perception of Recovery and Muscle Strength in Adolescents Aged 11 to 19 Engaged in Gras","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Strength; Stress; Exercise Adaptation","verify_url":"https://clinicaltrials.gov/study/NCT07890935"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157 STEC).","top_records":[{"recall_number":"H-0197-2027","firm":"Family Farmstead Dairy, LLC","classification":"Class I","location":"Worcester, NY","report_date":"20261111","reason":"Potential contamination with E. coli (pathogenic non-O157 STEC)."},{"recall_number":"H-0192-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"},{"recall_number":"H-0191-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"76045-214","generic_name":"Neostigmine Methylsulfate","brand_name":"Neostigmine Methylsulfate","dosage_form":"INJECTION, SOLUTION","labeler":"Fresenius Kabi USA, LLC","marketing_category":"NDA"},{"product_ndc":"76162-979","generic_name":"Avebonzone, Homosalate, Octisalate","brand_name":"Avebonzone, Homosalate, Octisalate","dosage_form":"SPRAY","labeler":"Topco Associates LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"76282-704","generic_name":"OSELTAMIVIR PHOSPHATE","brand_name":"OSELTAMIVIR PHOSPHATE","dosage_form":"CAPSULE","labeler":"Exelan Pharmaceuticals, Inc.","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"7K01AA029712-06","principal_investigator":"GRODIN, ERICA N","institution":"ARIZONA STATE UNIVERSITY-TEMPE CAMPUS","award_usd":100038,"title":"Characterizing the Microbiome-Gut-Brain Axis in Individuals with Alcohol Use Disorder","reporter_url":"https://reporter.nih.gov/project-details/11647352"},{"grant_id":"5P20GM139733-04","principal_investigator":"ZHANG, E (ALICE) ","institution":"UNIVERSITY OF KANSAS MEDICAL CENTER","award_usd":232500,"title":"Advancing OASIS Parent Training Toward Real-World Effectiveness in Community ABA Agencies","reporter_url":"https://reporter.nih.gov/project-details/11694438"}]}],"signal_sha256":"a5fae81bc335e0a115f9ee780dc3aca5a78016e9cfb7e5e0a424756c4380f057"}}
{"id":"synth_biomed-fda-grants_20261113-2045","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2045","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"6528d50d885ce7b871a1b5218f31e29b271c5d518b5226e2392f040c98f5f29f","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T20:45:45.334Z","slot_compact":"20261113-2045","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"6528d50d885ce7b871a1b5218f31e29b271c5d518b5226e2392f040c98f5f29f"}}
{"id":"synth_biomed-fda-grants_20261113-2145","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2145","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"3c10fb1b0a238cc343904b954a0adafdf1768e72b8e659ab2510a4484a908e16","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T21:45:45.436Z","slot_compact":"20261113-2145","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"3c10fb1b0a238cc343904b954a0adafdf1768e72b8e659ab2510a4484a908e16"}}
{"id":"synth_biomed-fda-grants_20261114-0845","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261114-0845","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"114b93bf440939d7835333458e8531ef9e4e27d5a5207f7303f365bd1ae36a70","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-14T08:45:45.696Z","slot_compact":"20261114-0845","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"114b93bf440939d7835333458e8531ef9e4e27d5a5207f7303f365bd1ae36a70"}}
{"id":"synth_biomed-fda-grants_20261114-2045","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261114-2045","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"058c36c67b1cfb6300636ce7f7d129174836f5223169a8960a21838a72b668fb","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-14T20:45:45.791Z","slot_compact":"20261114-2045","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"058c36c67b1cfb6300636ce7f7d129174836f5223169a8960a21838a72b668fb"}}
{"id":"synth_biomed-fda-grants_20261114-2345","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261114-2345","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"9a824c6026a957459e198ed9117e089dfc26634a3f36693654f12b96c842530c","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-14T23:45:45.205Z","slot_compact":"20261114-2345","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"9a824c6026a957459e198ed9117e089dfc26634a3f36693654f12b96c842530c"}}
{"id":"synth_biomed-fda-grants_20261115-0545","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261115-0545","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"162885fbc9a744ba979fc68f90814c4e893a970d336d0e37dfdebdddbb8a73dc","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-15T05:45:45.559Z","slot_compact":"20261115-0545","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"162885fbc9a744ba979fc68f90814c4e893a970d336d0e37dfdebdddbb8a73dc"}}
{"id":"synth_biomed-fda-grants_20261115-1145","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261115-1145","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"6f7c1af4a3ab3d55c0cb6db710b4c4e14807e2f179f4251594c9d5009dabc540","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-15T11:45:45.091Z","slot_compact":"20261115-1145","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"6f7c1af4a3ab3d55c0cb6db710b4c4e14807e2f179f4251594c9d5009dabc540"}}
{"id":"synth_biomed-fda-grants_20261113-1530","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-1530","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"bb4686b152bb174b9d51bff2a90cc470efebab03f8cb0549ec6c7f5bc210fc5b","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T15:30:43.405Z","slot_compact":"20261113-1530","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"76147-235","generic_name":"AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","brand_name":"StriVectin multi-action Super-C SPF 30","dosage_form":"CREAM","labeler":"StriVectin Operating Company, Inc.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"80425-0133","generic_name":"Pantoprazole Sodium","brand_name":"Pantoprazole Sodium DR","dosage_form":"TABLET, DELAYED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"},{"product_ndc":"80425-0396","generic_name":"VENLAFAXINE HYDROCHLORIDE","brand_name":"Venlafaxine Hydrochloride","dosage_form":"CAPSULE, EXTENDED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"bb4686b152bb174b9d51bff2a90cc470efebab03f8cb0549ec6c7f5bc210fc5b"}}
{"id":"synth_biomed-fda-grants_20261113-1630","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-1630","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"2d6d3318935b77a3dcffbe3cd176ea8ba074f6bd79a7322ae09c0c1521009d3f","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T16:30:43.471Z","slot_compact":"20261113-1630","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"76147-235","generic_name":"AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","brand_name":"StriVectin multi-action Super-C SPF 30","dosage_form":"CREAM","labeler":"StriVectin Operating Company, Inc.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"80425-0133","generic_name":"Pantoprazole Sodium","brand_name":"Pantoprazole Sodium DR","dosage_form":"TABLET, DELAYED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"},{"product_ndc":"80425-0396","generic_name":"VENLAFAXINE HYDROCHLORIDE","brand_name":"Venlafaxine Hydrochloride","dosage_form":"CAPSULE, EXTENDED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"2d6d3318935b77a3dcffbe3cd176ea8ba074f6bd79a7322ae09c0c1521009d3f"}}
{"id":"synth_biomed-fda-grants_20261113-1730","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-1730","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"62793de8c4d44dafedbceffb855a5c7ab481ed50b53de1a3352e2bb823e6ce6b","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T17:30:51.340Z","slot_compact":"20261113-1730","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"76147-235","generic_name":"AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","brand_name":"StriVectin multi-action Super-C SPF 30","dosage_form":"CREAM","labeler":"StriVectin Operating Company, Inc.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"80425-0133","generic_name":"Pantoprazole Sodium","brand_name":"Pantoprazole Sodium DR","dosage_form":"TABLET, DELAYED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"},{"product_ndc":"80425-0396","generic_name":"VENLAFAXINE HYDROCHLORIDE","brand_name":"Venlafaxine Hydrochloride","dosage_form":"CAPSULE, EXTENDED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"62793de8c4d44dafedbceffb855a5c7ab481ed50b53de1a3352e2bb823e6ce6b"}}
{"id":"synth_biomed-fda-grants_20261113-1830","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-1830","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"713412499fe5108d0b377406a2e6cd4cc785f76539e40e5527806b3982e8f447","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T18:30:52.273Z","slot_compact":"20261113-1830","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"76147-235","generic_name":"AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","brand_name":"StriVectin multi-action Super-C SPF 30","dosage_form":"CREAM","labeler":"StriVectin Operating Company, Inc.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"80425-0133","generic_name":"Pantoprazole Sodium","brand_name":"Pantoprazole Sodium DR","dosage_form":"TABLET, DELAYED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"},{"product_ndc":"80425-0396","generic_name":"VENLAFAXINE HYDROCHLORIDE","brand_name":"Venlafaxine Hydrochloride","dosage_form":"CAPSULE, EXTENDED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"713412499fe5108d0b377406a2e6cd4cc785f76539e40e5527806b3982e8f447"}}
{"id":"synth_biomed-fda-grants_20261113-1930","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-1930","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"b0115522df36822c98acfa31d932d8bd20fb9e205a5f8834bb39c3d550651f9f","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T19:30:46.493Z","slot_compact":"20261113-1930","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"76147-235","generic_name":"AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE","brand_name":"StriVectin multi-action Super-C SPF 30","dosage_form":"CREAM","labeler":"StriVectin Operating Company, Inc.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"80425-0133","generic_name":"Pantoprazole Sodium","brand_name":"Pantoprazole Sodium DR","dosage_form":"TABLET, DELAYED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"},{"product_ndc":"80425-0396","generic_name":"VENLAFAXINE HYDROCHLORIDE","brand_name":"Venlafaxine Hydrochloride","dosage_form":"CAPSULE, EXTENDED RELEASE","labeler":"Advanced Rx Pharmacy of Tennessee, LLC","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"b0115522df36822c98acfa31d932d8bd20fb9e205a5f8834bb39c3d550651f9f"}}
{"id":"synth_biomed-fda-grants_20261113-2100","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2100","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"ba77372f7a663bd90c32577492b7f5b90d1a19089e7514c526151cab7ac2337c","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T21:00:51.031Z","slot_compact":"20261113-2100","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"ba77372f7a663bd90c32577492b7f5b90d1a19089e7514c526151cab7ac2337c"}}
{"id":"synth_biomed-fda-grants_20261113-2115","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2115","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"db7e9e2732c85f5a8937aa07a9906033f67f0a47525423ad65dd10c5e5b3bc7b","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T21:15:51.334Z","slot_compact":"20261113-2115","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"db7e9e2732c85f5a8937aa07a9906033f67f0a47525423ad65dd10c5e5b3bc7b"}}
{"id":"synth_biomed-fda-grants_20261113-2130","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2130","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"5a54b76b7c25a1caccd4508620effddc3df42b309e59c302758e3b6aa8864d6a","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T21:30:45.213Z","slot_compact":"20261113-2130","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"5a54b76b7c25a1caccd4508620effddc3df42b309e59c302758e3b6aa8864d6a"}}
{"id":"synth_biomed-fda-grants_20261113-2200","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2200","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"569055c66b664c83cefa901e1630d0ac9b88186442c904c3bc10ac464886d9b9","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T22:00:51.812Z","slot_compact":"20261113-2200","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"569055c66b664c83cefa901e1630d0ac9b88186442c904c3bc10ac464886d9b9"}}
{"id":"synth_biomed-fda-grants_20261113-2215","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2215","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"2a4927be1a6a33db9fb4cf949af30234a7f76fe65f60ed5e298f5eebb6ec78ae","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T22:15:50.296Z","slot_compact":"20261113-2215","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"2a4927be1a6a33db9fb4cf949af30234a7f76fe65f60ed5e298f5eebb6ec78ae"}}
{"id":"synth_biomed-fda-grants_20261113-2230","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2230","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"401585eb249ec0bcc6317b7f968557815164c04a4841b764031de6b253c50519","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T22:30:46.938Z","slot_compact":"20261113-2230","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"401585eb249ec0bcc6317b7f968557815164c04a4841b764031de6b253c50519"}}
{"id":"synth_biomed-fda-grants_20261113-2245","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2245","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"059a373f21dc2539cf851488eb0aeee41d1a7961803726b386c60709d8e91282","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T22:45:51.807Z","slot_compact":"20261113-2245","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"059a373f21dc2539cf851488eb0aeee41d1a7961803726b386c60709d8e91282"}}
{"id":"synth_biomed-fda-grants_20261113-2300","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2300","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"a6db918067a8971f6baed55faed2ca800a44b1f73169a0a26f91fe9f1f07445f","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T23:00:50.003Z","slot_compact":"20261113-2300","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"a6db918067a8971f6baed55faed2ca800a44b1f73169a0a26f91fe9f1f07445f"}}
{"id":"synth_biomed-fda-grants_20261113-2315","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2315","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"52f64a9f9d9f438bd69a5cbc4df57bac47f4469c47b75f3da016976edeb96fd8","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T23:15:44.348Z","slot_compact":"20261113-2315","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"}]}],"signal_sha256":"52f64a9f9d9f438bd69a5cbc4df57bac47f4469c47b75f3da016976edeb96fd8"}}
{"id":"synth_biomed-fda-grants_20261113-2330","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2330","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"ee7c200c1cd5803b8876399a4cebf10841a22089ca206dbdf42cb6028dafdb0a","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T23:30:43.973Z","slot_compact":"20261113-2330","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"ee7c200c1cd5803b8876399a4cebf10841a22089ca206dbdf42cb6028dafdb0a"}}
{"id":"synth_biomed-fda-grants_20261113-2345","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261113-2345","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"04a0d19a89385dd1e5690a8d4121883e83e3dc4ca1336daf3c4ca4fd0b67d1f1","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-13T23:45:44.838Z","slot_compact":"20261113-2345","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"04a0d19a89385dd1e5690a8d4121883e83e3dc4ca1336daf3c4ca4fd0b67d1f1"}}
{"id":"synth_biomed-fda-grants_20261114-0000","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261114-0000","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"568cd16b994d4e5f815a0fff15b6763e7d6030db7d0dd6cf6a952c309aa27dd6","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-14T00:00:51.028Z","slot_compact":"20261114-0000","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women | [cold-chain] Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women","top_records":[{"nct_id":"NCT07936916","title":"Determinants of Physical Activity in Postmenopausal Women","status":"NOT_YET_RECRUITING","phase":"OBSERVATIONAL","conditions":"Postmenopause; Physical Activity","verify_url":"https://clinicaltrials.gov/study/NCT07936916"},{"nct_id":"NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","status":"RECRUITING","phase":"PHASE1/PHASE2","conditions":"Parkinson Disease; Parkinson Disease Dementia","verify_url":"https://clinicaltrials.gov/study/NCT07154511"},{"nct_id":"NCT07935447","title":"Microbial Contamination of Different Toothbrush Types Stored in Bathrooms and Rooms in Adolescents","status":"COMPLETED","phase":"NA","conditions":"Toothbrush Microbial Contamination","verify_url":"https://clinicaltrials.gov/study/NCT07935447"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0184-2027 (Class I) by GF Blends Inc: Products are recalled due to potential undeclared wheat gluten","top_records":[{"recall_number":"H-0184-2027","firm":"GF Blends Inc","classification":"Class I","location":"Richland, WA","report_date":"20261104","reason":"Products are recalled due to potential undeclared wheat gluten"},{"recall_number":"H-0177-2027","firm":"EDEN BROTHERS","classification":"Class I","location":"Arden, NC","report_date":"20261104","reason":"Salmonella"},{"recall_number":"H-0178-2027","firm":"Prosperity Organic Foods Inc","classification":"Class II","location":"Boise, ID","report_date":"20261104","reason":"Product recalled due to yeast, mold, and E. coli."}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"0283-1820","generic_name":"Benzocaine","brand_name":"HurriCaine Topical Anesthetic","dosage_form":"GEL","labeler":"Beutlich Pharmaceuticals, LLC","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"0299-4131","generic_name":"Salicylic Acid","brand_name":"Differin Acne Clearing Body Wash","dosage_form":"GEL","labeler":"Galderma Laboratories, L.P.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"63629-8844","generic_name":"neomycin sulfate, polymyxin b sulfate and hydrocortisone","brand_name":"Neomycin and Polymyxin B Sulfates and Hydrocortisone","dosage_form":"SUSPENSION","labeler":"Bryant Ranch Prepack","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"1F31DA067152-01","principal_investigator":"MOON, KYLE JOSEPH","institution":"JOHNS HOPKINS UNIVERSITY","award_usd":50114,"title":"Examining approaches to addressing homelessness and their impact on overdose: A multi-method study","reporter_url":"https://reporter.nih.gov/project-details/11459956"},{"grant_id":"1F32HD122330-01","principal_investigator":"JO, SEOKWON ","institution":"UNIVERSITY OF MINNESOTA","award_usd":76300,"title":"Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth","reporter_url":"https://reporter.nih.gov/project-details/11385229"}]}],"signal_sha256":"568cd16b994d4e5f815a0fff15b6763e7d6030db7d0dd6cf6a952c309aa27dd6"}}

Individual Paywalls Matching “NIH ClinicalTrials.gov Interventional Pipeline” (40)

Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (13:15 UTC)
clinical-trials.withsilex.com · 2026-11-12 13:15 UTC · Recently updated NIH study NCT07672483 (RECRUITING): IL-12 Genetically Engineered Myeloid Cells in Participant
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (14:45 UTC)
clinical-trials.withsilex.com · 2026-11-13 14:45 UTC · Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopaus
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (13:15 UTC)
clinical-trials.withsilex.com · 2026-11-16 13:15 UTC · Recently updated NIH study NCT07932509 (RECRUITING): Effect of Targeted Tracheal Kinesio Taping on Cough Effic
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (14:15 UTC)
clinical-trials.withsilex.com · 2026-11-17 14:15 UTC · Recently updated NIH study NCT07941791 (NOT_YET_RECRUITING): Acute Effects of Table Tennis, Resistance Band Tr
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Drop #1
clinical-trials.withsilex.com · 2026-11-11 00:12 UTC · Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological D
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Drop #2
clinical-trials.withsilex.com · 2026-11-11 00:12 UTC · Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological D
Single ($0.006) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (16:26 UTC)
clinical-trials.withsilex.com · 2026-11-11 16:26 UTC · Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological D
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (16:30 UTC)
clinical-trials.withsilex.com · 2026-11-11 16:30 UTC · Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological D
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (16:31 UTC)
clinical-trials.withsilex.com · 2026-11-11 16:31 UTC · Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological D
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (16:45 UTC)
clinical-trials.withsilex.com · 2026-11-11 16:45 UTC · Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological D
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (17:00 UTC)
clinical-trials.withsilex.com · 2026-11-11 17:00 UTC · Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological D
Single ($0.005) →
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (17:15 UTC)
clinical-trials.withsilex.com · 2026-11-11 17:15 UTC · Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological D
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (14:45 UTC)
dispatch.withsilex.com · 2026-11-13 14:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (13:15 UTC)
dispatch.withsilex.com · 2026-11-16 13:15 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (13:15 UTC)
dispatch.withsilex.com · 2026-11-12 13:15 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (14:15 UTC)
dispatch.withsilex.com · 2026-11-17 14:15 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (20:45 UTC)
dispatch.withsilex.com · 2026-11-13 20:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (21:45 UTC)
dispatch.withsilex.com · 2026-11-13 21:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (08:45 UTC)
dispatch.withsilex.com · 2026-11-14 08:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (20:45 UTC)
dispatch.withsilex.com · 2026-11-14 20:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (23:45 UTC)
dispatch.withsilex.com · 2026-11-14 23:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (05:45 UTC)
dispatch.withsilex.com · 2026-11-15 05:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (11:45 UTC)
dispatch.withsilex.com · 2026-11-15 11:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (15:30 UTC)
dispatch.withsilex.com · 2026-11-13 15:30 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (16:30 UTC)
dispatch.withsilex.com · 2026-11-13 16:30 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (17:30 UTC)
dispatch.withsilex.com · 2026-11-13 17:30 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (18:30 UTC)
dispatch.withsilex.com · 2026-11-13 18:30 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (19:30 UTC)
dispatch.withsilex.com · 2026-11-13 19:30 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (21:00 UTC)
dispatch.withsilex.com · 2026-11-13 21:00 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (21:15 UTC)
dispatch.withsilex.com · 2026-11-13 21:15 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (21:30 UTC)
dispatch.withsilex.com · 2026-11-13 21:30 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (22:00 UTC)
dispatch.withsilex.com · 2026-11-13 22:00 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (22:15 UTC)
dispatch.withsilex.com · 2026-11-13 22:15 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (22:30 UTC)
dispatch.withsilex.com · 2026-11-13 22:30 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (22:45 UTC)
dispatch.withsilex.com · 2026-11-13 22:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (23:00 UTC)
dispatch.withsilex.com · 2026-11-13 23:00 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (23:15 UTC)
dispatch.withsilex.com · 2026-11-13 23:15 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (23:30 UTC)
dispatch.withsilex.com · 2026-11-13 23:30 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (23:45 UTC)
dispatch.withsilex.com · 2026-11-13 23:45 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →
NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus (00:00 UTC)
dispatch.withsilex.com · 2026-11-14 00:00 UTC · Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recentl
Single ($0.005) →

Explore Related Keyword Topic Libraries

SEC EDGAR 8-K, 10-Q & 10-K Filings DHS CISA Zero-Day CVE Exploits Nano (XNO) Orderbook & Quorum Finality Federal IT & Cloud Contract Awards ERCOT Power Grid, Solar GHI & Geomagnetic Load FAA & NOAA Airport METAR Flight Rules NIH ClinicalTrials.gov Interventional Pipeline FDA Cold-Chain Recalls & NDC Drug Directory FEMA Municipal Emergency & Fire Declarations USGS Real-Time Seismic & Geospatial Events DOT & NHTSA Automotive & Motorcycle Recalls arXiv CS.AI, Cryptography & OpenAlex DOIs Post-Quantum Cryptography & WebCrypto Releases Bitcoin, ETH & SOL L2 CLOB Depth Imbalance